| Literature DB >> 33753713 |
Maogen Chen1, Weiqiang Ju1, Xiaohong Lin2, Yinghua Chen1, Qiang Zhao1, Zhiyong Guo1, Xiaoshun He1, Dongping Wang1.
Abstract
BACKGROUND Orthotopic liver transplantation has become the procedure of choice for end-stage liver disease. There are 3 commonly used methods of vena cava anastomosis. Here, we report a new technique for native hepatectomy. MATERIAL AND METHODS The data of 12 patients who underwent orthotopic liver transplantation using a new surgical technique were retrospectively collected for analysis. The new separation and reconstruction surgical technique mainly involved the second portal isolation and hepatectomy that followed. We performed recipient liver resection without the occlusion of the inferior vena cava, which was then followed by classic, piggyback, modified piggyback, or side-to-side orthotopic liver transplantation. The graft function index and complications were collected after transplantation. RESULTS The length of the anhepatic phase was 30.92±9.1 min. Alanine transaminase (ALT) levels were 138 to 2027 U/L, with a median of 361.5 U/L. The ALT levels of all patients gradually decreased to normal levels 7 to 10 days after surgery. Only 2 recipients had elevated levels of ALT higher than 1000 U/L. Four of 12 patients did not require red blood cell transfusion during surgery. Four patients appeared to have early allograft dysfunction, while others recovered smoothly. CONCLUSIONS This new surgical technique may shorten the anhepatic phase and decrease blood loss volume, aiding the success of liver transplant surgery. It can be used for most patients and does not increase the risk of complications or impair prognosis.Entities:
Year: 2021 PMID: 33753713 PMCID: PMC7999712 DOI: 10.12659/AOT.929259
Source DB: PubMed Journal: Ann Transplant ISSN: 1425-9524 Impact factor: 1.530
Figure 1Schematic diagram of the division technique for resection of native liver with preservation of the inferior vena cava (IVC). (A) Separation of the caudate lobe from retrohepatic IVC. (B) Find the interval of right hepatic vein and middle hepatic vein in the front of retrohepatic IVC. (C) Preparation for occlusion of both lateral hepatic vein. (D) Image after removal of native liver.
Patient demographic data and clinical characteristics.
| Patient number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62 | 62 | 35 | 52 | 45 | 68 | 38 | 59 | 57 | 54 | 50 | 65 | |
| F | M | F | M | M | M | M | M | M | M | M | M | |
| 24.7 | 29.8 | 25 | 23.1 | 24.3 | 28.6 | 21.6 | 24.7 | 18.4 | 26.6 | 21.3 | 21.7 | |
| HCC | HCC | LF | LC | HCC | LC | LC | LC | CHOL | HCC | CHOL | LC | |
| 107 | 153 | 99 | 64 | 152 | 103 | 101 | 94 | 139 | 74 | 147 | 100 | |
| 2.93 | 5.02 | 6.02 | 1.2 | 5.05 | 5.03 | 3.12 | 3.54 | 13.09 | 2.68 | 9.34 | 3.89 | |
| 57 | 147 | 27 | 46 | 154 | 75 | 41 | 74 | 362 | 43 | 229 | 37 | |
| 2.34 | 0.97 | 3.68 | 1.71 | 0.99 | 1.73 | 1.84 | 1.26 | 1.01 | 1.47 | 0.98 | 1.11 | |
| 138 | 139 | 133 | 138 | 142 | 141 | 133 | 140 | 133 | 139 | 141 | 140 | |
| 11 | 44 | 71 | 39 | 588 | 70 | 39 | 22 | 209 | 38 | 35 | 16 | |
| 58 | 24 | 72 | 73 | 986 | 92 | 37 | 31 | 82 | 91 | 21 | 26 | |
| 299.3 | 20.4 | 829 | 90.1 | 25.7 | 178.8 | 51.8 | 19.7 | 28.1 | 23.4 | 9.7 | 23.1 | |
| 2.7 | 5.1 | 8.3 | 6.4 | 3.8 | 6 | 5.5 | 3.1 | 4.5 | 5 | 6.1 | 3.7 | |
| 44 | 76 | 47 | 62 | 66 | 88 | 53 | 79 | 55 | 96 | 85 | 50 | |
| C | A | C | C | A | C | C | A | B | B | A | B | |
| C | A | C | C | A | C | C | A | B | B | A | B | |
| 24 | 5 | 25 | 13 | 6 | 21 | 10 | 8 | 14 | 13 | 5 | 4 | |
| 20 | 5 | 28 | 15 | 11 | 21 | 13 | 8 | 4 | 13 | 4 | 3 | |
| DBD | DBD | DBD | DBD | DBD | DCD | DBD | DCD | DBD | DBD | DBD | DBD | |
| 3 | 1 | 5 | 1.5 | 3 | 2 | 2 | 12 | 0.9 | 2.3 | 0.5 | 0.8 | |
| 63 | 22 | 50 | 30 | 23 | 29 | 31 | 12 | 20 | 21 | 16 | 15 |
ALT – alanine aminotransferase; AST – aspartate aminotransferase; BMI – body mass index; CHOL – cholangiocarcinoma; DCD – donation after circulatory death; DBD – donation after brain death; HCC – hepatocellular carcinoma; INR – international normalized ratio; LC – liver cirrhosis; LF – liver failure; MELD – model for end-stage liver disease.
Operation-related characteristics.
| Patient number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| no | no | no | no | yes | no | no | no | no | no | no | no | |
| 0 | 0 | 0 | 0 | 0 | 8 | 0 | 5 | 0 | 0 | 0 | 0 | |
| 4h28 | 12h08 | 6h43 | 5h22 | 6h06 | 9h33 | 4h59 | 5h06 | 6h25 | 11h07 | 4h30 | 2h36 | |
| 27 | 40 | 26 | 39 | 53 | 33 | 29 | 21 | 27 | 23 | 29 | 24 | |
| 4 | 0 | 16 | 15 | 0 | 16 | 8 | 6 | 0 | 8 | 0 | 10 | |
| 1100 | 700 | 2450 | 2200 | 800 | 1200 | 1200 | 900 | 1400 | 1250 | 600 | 2500 | |
| 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | |
| 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 1200 | 900 | 1400 | 800 | 2300 | 1200 | 1500 | 800 | 750 | 500 | 2300 | 2300 | |
| 600 | 800 | 5000 | 2400 | 700 | 3500 | 1000 | 1000 | 1000 | 600 | 900 | 2000 | |
| 306 | 372 | 366 | 372 | 8.4 | 7.5 | 5.3 | 7 | 6.3 | 6.5 | 7 | 5 |
IVC – inferior vena cava.
Figure 2Recovery of liver function in the first week after liver transplantation, including alanine transaminase (ALT), aspartate aminotransferase (AST), and total bilirubin (TBIL) value variation. The colored lines represent 4 of 12 recipients with the highest ALT values.